Cleveland Clinic’s recently launched laparoscopic living donor hepatectomy for liver transplant program has rapidly progressed to become the nation’s most active provider. A new report reviews the program’s progress and explains the steps necessary for success.
Cleveland Clinic surgeons have performed the Midwest’s first purely laparoscopic donor hepatectomy for living donor liver transplant, a technically demanding procedure that improves safety and shortens recovery times, possibly motivating more people to donate.
For pediatric patients, waiting for a donor liver can be risky. Transplant surgeon Dr. Koji Hashimoto explains that living donor transplant is a viable and somewhat underutilized alternative with superior outcomes and lower rejection risk.
World-renowned transplant surgeon David Kwon, MD, recently joined Cleveland Clinic’s Digestive Disease & Surgery Institute as Director of Laparoscopic Liver Surgery. He and Koji Hashimoto, MD, PhD, Director of Living Donor Liver Transplantation, discuss what Dr. Kwon’s arrival means for Cleveland Clinic’s LDLT program.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Living-donor liver transplantation is feasible for even the smallest pediatric patients. In this case study, read how it was done in a 2-year-old with progressive familial intrahepatic cholestasis (PFIC).
This case of living donor liver transplantation using a small left lobe graft allowed us to treat a patient with severe portal hypertension, avoiding a crisis due to the shortage of available donor organs.